| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Aβ42|Amyloid Beta 42|Aβ|1-42|Aβ1-42 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target |
Background
rat Aβ42 (Amyloid Beta 42) is a molecular target commonly studied in neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of Aβ42 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of Aβ42 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
Aβ42 (Amyloid Beta 42) may also be referenced as Aβ42, Amyloid Beta 42, and Aβ in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how Aβ42 relates to neuronal signaling and synaptic function, neuroinflammation, neurodegeneration models, and brain–body communication in neuroscience research.
- Interpreting shifts in Aβ42 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
Aβ42 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Unveiling the Therapeutic Potential of Kelulut (Stingless Bee) Honey in Alzheimer’s Disease: Findings from a Rat Model Study
IF: 6 Journal: Antioxidants Author: Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia Cited Date: 2024-08-02
Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer’s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis
IF: 5.8 Journal: International Journal of Pharmaceutics Author: Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt; Bio-Screening and Preclinical Trial Lab, Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt. Cited Date: 2024-05-17
Intranasal Dabigatran Etexilate Lipid Nanoparticles: A Targeted Approach for Management of Alzheimer's Disease
IF: 4.9 Journal: Journal of Drug Delivery Science and Technology Author: Department of Pharmaceutics, Division of Pharmaceutical Sciences. College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport, Alexandria, Egypt Cited Date: 2025-12-19
Effect of Edible Bird's Nest on Protecting against Cognitive Deficit and Ameliorating Beta‐Amyloid in Hippocampal Rats' Model of Cerebral Ischemia
IF: 3.5 Journal: Journal of Food Biochemistry Author: Faculty of Agro-Industry, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand Cited Date: 2024-07-19
Germacrone alleviates okadaic acid-induced neurotoxicity in PC12 cells via M1 muscarinic receptor-mediated Galphaq (Gq)/phospholipase C beta (PLCβ)/ protein kinase C (PKC) signaling
IF: 3.269 Journal: Bioengineered Cited Date: 2022-02-25
Therapeutic effects of crude extracts of Bacopa floribunda on beta-amyloid 1-42-induced Alzheimer’s disease via suppression of dyslipidemia, systemic inflammation and oxidative stress in male Wistar Rats
IF: Journal: Heliyon Cited Date: 2022-04-15
The effect of supplementation with selected micronutrients on dementia and osteoporosis
IF: Journal: American University in Cairo Digital Archive and Research Repository Cited Date: 2020-10-15
Trimetazidine attenuates neuroinflammation via TLR4/NF-KB pathway inhibition in lipopolysaccharides-induced dementia in rats
IF: Journal: Journal of Applied Pharmaceutical Science Author: Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. Cited Date: 2024-04-12